Vascular Biogenics Stock Filter Stocks by Fundamentals
VBLTDelisted Stock | USD 0.16 0.01 5.88% |
Vascular Biogenics fundamentals help investors to digest information that contributes to Vascular Biogenics' financial success or failures. It also enables traders to predict the movement of Vascular Stock. The fundamental analysis module provides a way to measure Vascular Biogenics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vascular Biogenics stock.
Vascular |
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
All Next | Launch Module |
Vascular Fundamentals
Return On Equity | -0.6 | |||
Return On Asset | -0.29 | |||
Operating Margin | (33.89) % | |||
Current Valuation | (10.99 M) | |||
Shares Outstanding | 77.64 M | |||
Shares Owned By Insiders | 13.48 % | |||
Shares Owned By Institutions | 14.00 % | |||
Number Of Shares Shorted | 250.34 K | |||
Price To Earning | (9.32) X | |||
Price To Book | 0.35 X | |||
Price To Sales | 9.63 X | |||
Revenue | 658 K | |||
Gross Profit | 554 K | |||
EBITDA | (31.16 M) | |||
Net Income | (32.3 M) | |||
Cash And Equivalents | 34.15 M | |||
Cash Per Share | 0.49 X | |||
Total Debt | 564 K | |||
Debt To Equity | 0.05 % | |||
Current Ratio | 4.05 X | |||
Book Value Per Share | 0.27 X | |||
Cash Flow From Operations | (31.59 M) | |||
Short Ratio | 0.55 X | |||
Earnings Per Share | (0.18) X | |||
Target Price | 5.0 | |||
Beta | 0.71 | |||
Market Capitalization | 13.83 M | |||
Total Asset | 29.66 M | |||
Retained Earnings | (294.38 M) | |||
Working Capital | 15.42 M | |||
Current Asset | 38.59 M | |||
Current Liabilities | 4.16 M | |||
Z Score | -2.01 | |||
Net Asset | 29.66 M |
About Vascular Biogenics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vascular Biogenics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vascular Biogenics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vascular Biogenics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vascular Biogenics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vascular Biogenics' short interest history, or implied volatility extrapolated from Vascular Biogenics options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |